British American Tobacco Industries p.l.c. (BTI) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
British American Tobacco Industries p.l.c. (BTI) has outperformed Regencell Bioscience (RGC) over the past year, gaining 7.4% versus a loss of 60.7%. Over five years, RGC leads with a +1455.6% price change compared with +53.5% for BTI. British American Tobacco Industries p.l.c. is the larger company by market cap ($119.45 billion vs $3.64 billion), about 32.8 times the size.
British American Tobacco Industries p.l.c. pays a dividend yielding 4.41%, while Regencell Bioscience does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTI | RGC |
|---|---|---|
| Share price | $55.53 | $7.35 |
| Market cap | $119.45B | $3.64B |
| 1-day change | +0.18% | -3.66% |
| YTD return | -2.10% | -63.67% |
| 1-year return | +7.42% | -60.67% |
| 5-year return | +53.55% | +1455.56% |
| P/E ratio (TTM) | 14.24 | — |
| Forward P/E | 10.60 | — |
| EPS (TTM) | $3.90 | $-0.02 |
| Dividend yield | 4.41% | 0.00% |
| Annual dividend | $2.45 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $67.30 | $69.00 |
| 52-week low | $49.88 | $4.51 |
| Distance from 52-week high | -17.49% | -89.35% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +26.83% | — |
| Average volume | 4.60M | 199.19K |
| Shares outstanding | 2.15B | 495.88M |
| Employees | 47,797 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- British American Tobacco Industries p.l.c. is about 32.8 times larger than Regencell Bioscience by market value ($119.45B vs $3.64B).
- BTI has outperformed RGC by 68.1 percentage points over the past year.
- British American Tobacco Industries p.l.c. offers a meaningfully higher dividend yield (4.41% vs 0.00%).
About British American Tobacco Industries p.l.c.
BTI stock →British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa.
Health Care · Medicinal Chemicals and Botanical Products · 47,797 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
BTI vs RGC FAQ
Which is bigger, British American Tobacco Industries p.l.c. or Regencell Bioscience?
British American Tobacco Industries p.l.c. (BTI) is larger, with a market capitalization of $119.45B compared with $3.64B for Regencell Bioscience (RGC).
Which stock has performed better over the past year, BTI or RGC?
BTI returned +7.42% over the past 12 months, compared with -60.67% for RGC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, British American Tobacco Industries p.l.c. or Regencell Bioscience?
British American Tobacco Industries p.l.c. pays a dividend yielding 4.41%, while Regencell Bioscience does not currently pay a regular dividend.
Are British American Tobacco Industries p.l.c. and Regencell Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.